Celgene Corporation (NASDAQ: CELG) is supposed to be one of the more promising biotechs out there. After all it was worth some $29.6 billion in market capitalization at Wednesday’s close. Now shares are down more than 12% and destroying more than $3 billion in market value.
The biotech giant announced that it has now withdrawn its new indication submission for Revlimid to European regulators. Revlimid is ultimately seeking approval for the cancer multiple myeloma which affects certain white blood cells. While today’s implosion is a bad one, Celgene was quick to not that it plans to resubmit its Revlimid application with more current data.
Celgene also said that it is re-evaluating Revlimid’s newly diagnosed submission to the U.S. Food and Drug Administration. It is now targeting a new drug application with the FDA at some point in 2013. The company said that it will continue with applications for Revlimid in Switzerland, Australia and other markets.
Thomson Reuters had estimates of $4.79 EPS and $5.47 billion in sales in 2012 and the consensus was $5.61 EPS and $6.17 billion in revenues in 2013. Analysts will likely be taking those figures down for sales and for higher R&D expenses. The consensus price target before this news came out was almost $85.00.
Celgene shares had already been having problems as the $67.16 close compared to a 52-week trading range of $51.70 to $80.42. Now shares are down about 12% and trading closer to $59.00 in active trading.
JON C. OGG
The Average American Has No Idea How Much Money You Can Make Today (Sponsor)
The last few years made people forget how much banks and CD’s can pay. Meanwhile, interest rates have spiked and many can afford to pay you much more, but most are keeping yields low and hoping you won’t notice.
But there is good news. To win qualified customers, some accounts are paying almost 10x the national average! That’s an incredible way to keep your money safe and earn more at the same time. Our top pick for high yield savings accounts includes other benefits as well. You can earn up to 3.80% with a Checking & Savings Account today Sign up and get up to $300 with direct deposit. No account fees. FDIC Insured.
Click here to see how much more you could be earning on your savings today. It takes just a few minutes to open an account to make your money work for you.
Our top pick for high yield savings accounts includes other benefits as well. You can earn up to 4.00% with a Checking & Savings Account from Sofi. Sign up and get up to $300 with direct deposit. No account fees. FDIC Insured.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
Latest from 24/7
Our expert who first called NVIDIA in 2009 is predicting 2025 will see a historic AI breakthrough.
You can follow him investing $500,000 of his own money on our top AI stocks for free.